Peritoneal Dialysis and Peritonitis: Are You at Risk?
"Unveiling the Risk Factors of Peritonitis in Peritoneal Dialysis Patients"
For individuals facing end-stage renal disease (ESRD), peritoneal dialysis (PD) offers a vital lifeline, providing a home-based alternative to hemodialysis. PD allows patients to maintain a greater sense of independence and a better quality of life. Yet, like all medical treatments, it comes with potential complications, the most concerning of which is peritonitis.
Peritonitis, an inflammation of the peritoneum (the membrane lining the abdominal cavity), poses a significant threat to PD patients. It can lead to poor dialysis outcomes, membrane damage, and even PD failure, ultimately reducing a patient's quality of life. Understanding the factors that increase the risk of peritonitis is crucial for prevention and improved management.
This article translates the findings of a research study focused on identifying these risk factors in PD patients. By understanding the factors that predispose individuals to peritonitis, patients and healthcare providers can work together to minimize risk and optimize the benefits of PD therapy.
Why Peritonitis Matters
Peritonitis is a recognized complication of peritoneal dialysis that can affect treatment continuity and patient well-being. Its likelihood and consequences vary among individuals and care settings. Patients should discuss symptoms, prevention, and urgent evaluation plans with their kidney-care team.
Guidelines and Their Limits
Management is guided by evidence-based recommendations and educational materials from the International Society for Peritoneal Dialysis (ISPD). The ISPD 2022 update revised and clarified definitions for refractory and relapsing peritonitis, catheter removal, transfer to hemodialysis, peritonitis-associated death, and hospitalization. A review of peritoneal dialysis-associated peritonitis also highlights common management mistakes and controversies that may compromise treatment success. The guidelines identify prevention and treatment as areas requiring further research.
An Evolving Field
The management of peritoneal dialysis-associated peritonitis has developed through successive clinical guidance and research. Current practice continues to refine definitions, treatment approaches, and prevention strategies. The available material also indicates that important questions remain under investigation.
What Factors Increase Your Risk of Peritonitis During Peritoneal Dialysis?
A recent study investigated the potential risk factors associated with peritonitis in 115 patients undergoing PD therapy, comparing those who experienced peritonitis with those who did not. The research identified several key factors that significantly correlated with the occurrence of peritonitis:
- Low Serum Albumin: Albumin is a protein in your blood, and low levels (below 29.1 g/L) can compromise your immune system and increase susceptibility to infection. The study found that low serum albumin was a significant risk factor (p<0.001).
- Low Blood Phosphorus: Phosphorus is an essential mineral, but low levels (below 1.795 mmol/L) were also linked to increased peritonitis risk (p=0.001).
- Gastrointestinal Issues: A history of gastrointestinal disorders, like diarrhea or constipation, significantly elevated the risk of peritonitis (p=0.043).
- Calcitriol Use: Interestingly, the use of calcitriol, a form of vitamin D often prescribed to manage mineral and bone disorders in dialysis patients, was associated with a reduced risk of peritonitis (p=0.048).
Current Evidence
Recent reviews continue to examine how peritoneal dialysis-associated peritonitis is recognized, managed, and prevented. Research in this area appears to focus on improving outcomes while addressing unresolved clinical questions. Because no specific study findings were provided here, the latest evidence should be interpreted through the full published research rather than through a single summary.
Why Treatment Can Fail
Peritonitis is described as a severe complication of peritoneal dialysis and an important cause of treatment failure and patient dropout. One study specifically sought predictors of treatment failure and developed a risk score for affected patients. Reviews identify mistakes and misconceptions in management that can compromise treatment success. These findings challenge the assumption that standard treatment will produce uniform outcomes for every patient.
Comparing PD Contexts
Peritoneal dialysis-related peritonitis can be classified by cause, relation to catheter implantation, exit-site or tunnel infection, timing after previous episodes, and outcome. A separate treatment presentation reports that no relapsing episodes occurred in patients with a mean serum vancomycin trough above 16 mg/L, a level higher than the 15 mg/L recommendation cited from ISPD. These observations suggest that patient classification and treatment context may influence outcomes. The reported vancomycin figures come from the presentation and should not be treated as a universal result for all patients.
Taking Control: What Can You Do to Minimize Your Risk?
While some risk factors, such as pre-existing gastrointestinal issues, might be difficult to eliminate, others are modifiable. Here's what you can discuss with your healthcare team:
Where Practice Needs Clarity
Expert reviews emphasize risk factors, diagnosis, treatment, prevention, variable practices, and unresolved controversies in peritoneal dialysis-related peritonitis. A newer report notes that current treatment guidelines are directed toward continuous ambulatory peritoneal dialysis (CAPD), while optimal treatment for automated peritoneal dialysis (APD) is less clear. Together, these sources support continued efforts to adapt evidence to different dialysis modalities. They also identify research as necessary to resolve practice gaps.
Tracking Progress
Peritoneal dialysis-related peritonitis remains a priority for care and research, with registries examining rates and trends across national and regional populations. Research has also examined peritonitis rates and the relationship between facility practices and risk in countries participating in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). An analysis of the national burden from 2016 to 2020 further highlights changes in demographics, treatment practices, and in-hospital outcomes. Future progress will depend on comparing these patterns and identifying practices associated with better outcomes.
Beyond the Infection
Peritonitis outcomes can extend beyond the immediate dialysis episode. A 2026 study reports that recent peritonitis, defined as occurring within six months before transplantation, was associated with higher risks of acute rejection and graft failure. It also reports that peritonitis requiring transfer to hemodialysis was associated with increased graft-failure risk. Other research has examined the likelihood of cure after an episode in relation to patient, peritonitis, and treatment characteristics.
Recognizing the Patient Experience
A retrospective case-control study found that a higher neutrophil-to-lymphocyte ratio (NLR), measured up to three months before clinical presentation, was independently associated with increased risk of developing peritoneal dialysis-associated peritonitis. This finding may help researchers evaluate warning signals before symptoms appear, although it does not replace clinical assessment. A nursing case study focuses on recognizing peritonitis, assessing complications, managing infection, and providing evidence-based renal nursing care. Together, the sources underscore the importance of both clinical indicators and practical patient care.
<ul> <li><b>Monitor Albumin and Phosphorus Levels:</b> Regular blood tests can track these levels. Work with your doctor and a registered dietitian to optimize your nutrition and address any deficiencies through diet or supplements.</li> <li><b>Manage Gastrointestinal Health:</b> If you experience frequent diarrhea or constipation, seek medical advice. Addressing these issues can improve your overall health and potentially reduce your peritonitis risk.</li> <li><b>Discuss Calcitriol with Your Doctor:</b> If you're not currently taking calcitriol, discuss the potential benefits and risks with your physician. The study suggests it may offer some protection against peritonitis.</li> </ul>
Remember, proactive communication with your healthcare team is key to successful PD therapy. By understanding your individual risk factors and working collaboratively, you can minimize complications and enjoy a better quality of life.